GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Stock Based Compensation

Hindustan Bio Sciences (BOM:532041) Stock Based Compensation : ₹0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Stock Based Compensation?

Hindustan Bio Sciences's Stock Based Compensation for the three months ended in Dec. 2023 was ₹0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00 Mil.


Hindustan Bio Sciences Stock Based Compensation Historical Data

The historical data trend for Hindustan Bio Sciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Stock Based Compensation Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hindustan Bio Sciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.


Hindustan Bio Sciences Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines